CReATe: Investigating Neurofilament Light Chain as a Biomarker for Amyotrophic Lateral Sclerosis
20 de ene. de 2023 ·
2m 38s
Regístrate gratis
Escucha este episodio y muchos más. ¡Disfruta de los mejores podcasts en Spreaker!
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
New research from the Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium. This summary is based on a paper published in the journal Brain on October...
mostra más
New research from the Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium. This summary is based on a paper published in the journal Brain on October 31, 2022, titled "Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal."
Read the paper here: https://academic.oup.com/brain/advance-article/doi/10.1093/brain/awac394/6780887?login=false
Learn more about CReATe: https://www1.rarediseasesnetwork.org/cms/create/
mostra menos
Read the paper here: https://academic.oup.com/brain/advance-article/doi/10.1093/brain/awac394/6780887?login=false
Learn more about CReATe: https://www1.rarediseasesnetwork.org/cms/create/
Información
| Autor | RDCRN |
| Organización | RDCRN |
| Página web | - |
| Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
